Follow
Manasi Das
Manasi Das
Assistant Project Scientist II, University of California, San Diego, USA
No verified email
Title
Cited by
Cited by
Year
Ligand-based targeted therapy for cancer tissue
M Das, C Mohanty, SK Sahoo
Expert opinion on drug delivery 6 (3), 285-304, 2009
2732009
Sustained wound healing activity of curcumin loaded oleic acid based polymeric bandage in a rat model
C Mohanty, M Das, SK Sahoo
Molecular pharmaceutics 9 (10), 2801-2811, 2012
2292012
Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin
C Mohanty, M Das, SK Sahoo
Expert opinion on drug delivery 9 (11), 1347-1364, 2012
1872012
Receptor mediated tumor targeting: an emerging approach for cancer therapy
C Mohanty, M Das, J R Kanwar, S K Sahoo
Current drug delivery 8 (1), 45-58, 2011
1382011
Delivery of dual drug loaded lipid based nanoparticles across the blood–brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson’s disease
P Kundu, M Das, K Tripathy, SK Sahoo
ACS chemical neuroscience 7 (12), 1658-1670, 2016
1262016
Multifunctional nanoparticle–EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy
M Das, W Duan, SK Sahoo
Nanomedicine: Nanotechnology, Biology and Medicine 11 (2), 379-389, 2015
1212015
Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance
M Das, SK Sahoo
PloS one 7 (3), e32920, 2012
1212012
Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer
G Arya, M Das, SK Sahoo
Biomedicine & pharmacotherapy 102, 555-566, 2018
1192018
Degradation of splicing factor SRSF3 contributes to progressive liver disease
D Kumar, M Das, C Sauceda, LG Ellies, K Kuo, P Parwal, M Kaur, L Jih, ...
The Journal of clinical investigation 129 (10), 4477-4491, 2019
812019
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
A Mohanty, N Sandoval, M Das, R Pillai, L Chen, RW Chen, HM Amin, ...
Oncotarget 7 (45), 73558, 2016
792016
Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly (lactide-co-glycolide) nanoformulation
R Misra, M Das, BS Sahoo, SK Sahoo
International journal of pharmaceutics 475 (1-2), 372-384, 2014
682014
Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models
M Das, LG Ellies, D Kumar, C Sauceda, A Oberg, E Gross, T Mandt, ...
Nature communications 12 (1), 565, 2021
572021
Mitochondrial dysfunction in obesity and reproduction
M Das, C Sauceda, NJG Webster
Endocrinology 162 (1), bqaa158, 2021
492021
Targeted nutlin-3a loaded nanoparticles inhibiting p53–MDM2 interaction: novel strategy for breast cancer therapy
M Das, F Dilnawaz, SK Sahoo
Nanomedicine 6 (3), 489-507, 2011
362011
Hepatocyte deletion of IGF2 prevents DNA damage and tumor formation in hepatocellular carcinoma
D Kumar, M Das, A Oberg, D Sahoo, P Wu, C Sauceda, L Jih, LG Ellies, ...
Advanced Science 9 (21), 2105120, 2022
172022
Obesity, cancer risk, and time-restricted eating
M Das, NJG Webster
Cancer and Metastasis Reviews 41 (3), 697-717, 2022
152022
Nanotechnology in Health Care
SK Sahoo, SK Sahoo
Pan Stanford, 2012
122012
EGFR targeted Mn-doped ZnO fluorescent nanocrystals for cancer theranostic application
R Misra, M Das, P Biswas, A Nanda
Materials Today Communications 26, 102170, 2021
92021
Space-Time Geometry of Electromagnetic Field in the System of Photon
M Das, R Misra
International Letters of Chemistry, Physics and Astronomy 9, 13-16, 2013
62013
Stimulating antitumoral immunity by percutaneous cryoablation and combination immunoadjuvant therapy in a murine model of hepatocellular carcinoma
T Mandt, A Bangar, C Sauceda, M Das, C Moderbacher, M Ghani, ...
Journal of Vascular and Interventional Radiology 34 (9), 1516-1527. e6, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–20